Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030563123> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2030563123 endingPage "589" @default.
- W2030563123 startingPage "584" @default.
- W2030563123 abstract "An open, 12-week, multicentre study was conducted to assess the efficacy of piritrexim isethionate in the treatment of severe psoriasis. Piritrexim isethionate is a lipid-soluble dihydrofolate reductase inhibitor which cannot form polyglutamates, and may be as effective as methotrexate in the treatment of psoriasis. If, as is suspected, but as yet unproven, methotrexate polyglutamates are responsible for the hepatotoxicity of methotrexate, piritrexim should be less hepatotoxic, and may offer an alternative to methotrexate therapy. Fifty-five patients were enrolled, of whom 41 completed the study. Patients were allocated to receive either 150, 225, 300, or 450 mg of piritrexim weekly, in divided doses over 72 h (low-dose groups, 150 and 225 mg), or over 36 h (300 and 450 mg groups). Twenty-four of the 41 patients who completed the study had a greater than 50% improvement in the severity of their psoriasis, as demonstrated by a reduction in the Psoriasis Severity Score, a measure analogous to the PASI scoring system. Adverse events were common, but mild, and were controlled by dose reduction. Piritrexim appears to be an effective therapy for severe psoriasis at doses of 300 and 450 mg weekly, in three divided doses over 36 h." @default.
- W2030563123 created "2016-06-24" @default.
- W2030563123 creator A5010870176 @default.
- W2030563123 creator A5040997794 @default.
- W2030563123 creator A5042715636 @default.
- W2030563123 creator A5053161494 @default.
- W2030563123 creator A5063266899 @default.
- W2030563123 creator A5069134943 @default.
- W2030563123 creator A5070061498 @default.
- W2030563123 creator A5072986542 @default.
- W2030563123 creator A5073716582 @default.
- W2030563123 creator A5080254218 @default.
- W2030563123 creator A5082478721 @default.
- W2030563123 date "1993-11-01" @default.
- W2030563123 modified "2023-10-04" @default.
- W2030563123 title "A multicentre 12-week open study of a lipid-soluble folate antagonist, piritrexim in severe psoriasis" @default.
- W2030563123 cites W1593305408 @default.
- W2030563123 cites W1628641593 @default.
- W2030563123 cites W2000520160 @default.
- W2030563123 cites W2027846395 @default.
- W2030563123 cites W2047345753 @default.
- W2030563123 cites W2048183147 @default.
- W2030563123 cites W2079914607 @default.
- W2030563123 cites W2106625719 @default.
- W2030563123 cites W2109505122 @default.
- W2030563123 cites W4230466570 @default.
- W2030563123 cites W4233665812 @default.
- W2030563123 cites W4243344211 @default.
- W2030563123 cites W4294350064 @default.
- W2030563123 doi "https://doi.org/10.1111/j.1365-2133.1993.tb00489.x" @default.
- W2030563123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8251356" @default.
- W2030563123 hasPublicationYear "1993" @default.
- W2030563123 type Work @default.
- W2030563123 sameAs 2030563123 @default.
- W2030563123 citedByCount "15" @default.
- W2030563123 countsByYear W20305631232013 @default.
- W2030563123 countsByYear W20305631232021 @default.
- W2030563123 crossrefType "journal-article" @default.
- W2030563123 hasAuthorship W2030563123A5010870176 @default.
- W2030563123 hasAuthorship W2030563123A5040997794 @default.
- W2030563123 hasAuthorship W2030563123A5042715636 @default.
- W2030563123 hasAuthorship W2030563123A5053161494 @default.
- W2030563123 hasAuthorship W2030563123A5063266899 @default.
- W2030563123 hasAuthorship W2030563123A5069134943 @default.
- W2030563123 hasAuthorship W2030563123A5070061498 @default.
- W2030563123 hasAuthorship W2030563123A5072986542 @default.
- W2030563123 hasAuthorship W2030563123A5073716582 @default.
- W2030563123 hasAuthorship W2030563123A5080254218 @default.
- W2030563123 hasAuthorship W2030563123A5082478721 @default.
- W2030563123 hasConcept C126322002 @default.
- W2030563123 hasConcept C16005928 @default.
- W2030563123 hasConcept C197934379 @default.
- W2030563123 hasConcept C2777011040 @default.
- W2030563123 hasConcept C2778397455 @default.
- W2030563123 hasConcept C2780564577 @default.
- W2030563123 hasConcept C2781059491 @default.
- W2030563123 hasConcept C2781382166 @default.
- W2030563123 hasConcept C71924100 @default.
- W2030563123 hasConcept C90924648 @default.
- W2030563123 hasConcept C98274493 @default.
- W2030563123 hasConceptScore W2030563123C126322002 @default.
- W2030563123 hasConceptScore W2030563123C16005928 @default.
- W2030563123 hasConceptScore W2030563123C197934379 @default.
- W2030563123 hasConceptScore W2030563123C2777011040 @default.
- W2030563123 hasConceptScore W2030563123C2778397455 @default.
- W2030563123 hasConceptScore W2030563123C2780564577 @default.
- W2030563123 hasConceptScore W2030563123C2781059491 @default.
- W2030563123 hasConceptScore W2030563123C2781382166 @default.
- W2030563123 hasConceptScore W2030563123C71924100 @default.
- W2030563123 hasConceptScore W2030563123C90924648 @default.
- W2030563123 hasConceptScore W2030563123C98274493 @default.
- W2030563123 hasIssue "5" @default.
- W2030563123 hasLocation W20305631231 @default.
- W2030563123 hasLocation W20305631232 @default.
- W2030563123 hasOpenAccess W2030563123 @default.
- W2030563123 hasPrimaryLocation W20305631231 @default.
- W2030563123 hasRelatedWork W1983452506 @default.
- W2030563123 hasRelatedWork W1990897910 @default.
- W2030563123 hasRelatedWork W2000659631 @default.
- W2030563123 hasRelatedWork W2001582869 @default.
- W2030563123 hasRelatedWork W2030563123 @default.
- W2030563123 hasRelatedWork W2068695759 @default.
- W2030563123 hasRelatedWork W2137251947 @default.
- W2030563123 hasRelatedWork W2963043097 @default.
- W2030563123 hasRelatedWork W4233702843 @default.
- W2030563123 hasRelatedWork W2403984562 @default.
- W2030563123 hasVolume "129" @default.
- W2030563123 isParatext "false" @default.
- W2030563123 isRetracted "false" @default.
- W2030563123 magId "2030563123" @default.
- W2030563123 workType "article" @default.